Opportunity Information: Apply for CDC RFA GH15 159002CONT16
Apply for CDC RFA GH15 159002CONT16
- The HHS-CDC in the health sector is offering a public funding opportunity titled "Provision of comprehensive HIV/AIDS and TB services including prevention, care, support and treatment to prisoners and staff of the prisons service in the Republic of Uganda under the President’s Emergency Plan for AIDS Relief" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Dec 08, 2015 and posted on Dec 08, 2015.
- Applicants must submit their applications by Dec 16, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity is a continuation cooperative agreement from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC), focused on strengthening and sustaining comprehensive HIV/AIDS and tuberculosis (TB) services for both prisoners and staff within the Uganda Prisons Service. It sits under the President's Emergency Plan for AIDS Relief (PEPFAR) framework and is categorized as a health activity under CFDA 93.067. In practical terms, the opportunity is aimed at supporting an ongoing program rather than launching a brand-new initiative, with CDC Uganda continuing to work alongside the recipient through a cooperative agreement structure, which typically means substantial CDC involvement in technical direction, monitoring, and program oversight.
The core purpose is to ensure that people living and working in prison settings in Uganda have access to a full package of HIV and TB services across the prevention-to-treatment continuum. That includes prevention interventions (such as risk reduction education and other evidence-based prevention approaches suited to closed and high-risk settings), HIV testing services with effective linkage to care, clinical treatment services (including antiretroviral therapy for HIV), and ongoing care and support to help individuals remain engaged in treatment over time. Because prisons are environments where transmission risks can be elevated and continuity of care can be disrupted by transfers, releases, or resource constraints, the emphasis on comprehensive services signals a program design that addresses multiple steps at once: identifying infections early, initiating appropriate treatment, supporting adherence, and ensuring follow-up.
A second major pillar is TB services integrated with HIV programming, reflecting the well-established relationship between HIV and TB co-infection and the high burden of TB in many congregate settings. "Comprehensive" TB services generally implies systematic screening and evaluation for TB symptoms, diagnostic testing pathways, appropriate treatment initiation and follow-up, and prevention strategies such as infection control measures in facilities. In the prison context, this often involves strengthening facility-level procedures to detect TB quickly, reduce transmission within crowded conditions, and manage co-infected patients in a coordinated way so that HIV and TB care are not fragmented.
The target population is explicitly twofold: incarcerated individuals and prison staff. Including staff is important because staff members are part of the same transmission network and may face occupational exposures, while also serving as a bridge population between prisons and surrounding communities. Programming that covers both groups can improve health outcomes inside facilities and reduce broader community impact as staff return home daily and as prisoners are released back into the community.
Administratively, the opportunity is identified by Funding Opportunity Number CDC RFA GH15-159002CONT16. It is listed as a continuation opportunity, with an expected single award (ExpectedAwards: 1), suggesting that CDC anticipated funding one implementing partner, often the incumbent organization already carrying out this work. The award ceiling is listed as 0, which in many federal listings indicates that a specific ceiling amount was not published in the synopsis or is defined elsewhere in the full announcement or continuation documentation. The closing date for applications was December 16, 2015 (both the original and current closing date), and the notice was created and posted on December 8, 2015, indicating a short turnaround typical of continuation actions where eligible applicants are limited and the goal is uninterrupted service delivery.
Eligibility is described broadly as "Others," with direction to consult the additional eligibility text in the full announcement for specifics. In continuation cooperative agreements, eligibility is often restricted to organizations that are already funded under the preceding project period or that meet narrow criteria tied to the existing program, which aligns with the single expected award and the continuation category. The funding instrument being a cooperative agreement is also a key detail: compared with a standard grant, it usually involves closer collaboration with CDC, including jointly agreed work plans, CDC-provided technical assistance, and more structured performance monitoring.
Overall, this opportunity is best understood as CDC Uganda, under PEPFAR, maintaining and improving a national-level prison HIV/TB program by funding one partner to deliver and coordinate prevention, testing, treatment, and support services for prisoners and prison staff. The intent is not only to provide clinical services but to strengthen systems inside the prisons to consistently identify HIV and TB, link people to appropriate care, sustain treatment, and address the unique operational challenges of correctional environments in Uganda.
Frequently Asked Questions (FAQs)
What is this funding opportunity about?
This opportunity is a continuation cooperative agreement from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC). It focuses on strengthening and sustaining comprehensive HIV/AIDS and tuberculosis (TB) services for prisoners and prison staff within the Uganda Prisons Service, under the President's Emergency Plan for AIDS Relief (PEPFAR) framework.
Is this meant to start a new project or continue an existing one?
It is designed to support an ongoing program rather than launch a brand-new initiative. The listing describes it as a continuation opportunity, which generally means the work is intended to continue without interruption and build on what is already in place.
Who is the funding agency and where is the program situated?
The funding agency is HHS-CDC. The work is described in the context of CDC Uganda continuing to work alongside the recipient to support services within the Uganda Prisons Service.
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA GH15-159002CONT16.
What type of funding instrument is this?
This opportunity uses a cooperative agreement. That typically indicates substantial CDC involvement in areas like technical direction, monitoring, and program oversight, rather than a more hands-off grant structure.
What does "cooperative agreement" mean in practical terms for this program?
Based on the description provided, a cooperative agreement structure usually means CDC Uganda remains actively involved with the recipient through collaboration on technical direction, monitoring, and structured performance oversight, including jointly agreed work plans and CDC-provided technical assistance.
What is the main purpose of the program?
The core purpose is to ensure people living and working in Uganda prison settings have access to a full package of HIV and TB services across the prevention-to-treatment continuum. The intent is to provide comprehensive services and strengthen systems inside prisons to identify infections early, initiate treatment, support adherence, and ensure follow-up despite operational challenges like transfers or release.
Who is the target population for services?
The target population is explicitly twofold: incarcerated individuals and prison staff within the Uganda Prisons Service.
Why does the program include prison staff as well as prisoners?
The description notes that staff are part of the same transmission network and may face occupational exposures. Staff can also serve as a bridge population between prisons and surrounding communities, so covering both groups can improve health outcomes in facilities and reduce broader community impact.
What HIV services are included in the "comprehensive" package?
The opportunity emphasizes services across the prevention-to-treatment continuum, including prevention interventions (such as risk reduction education and other evidence-based approaches suited to closed and high-risk settings), HIV testing services with effective linkage to care, clinical treatment services (including antiretroviral therapy for HIV), and ongoing care and support to help individuals remain engaged in treatment over time.
What kinds of prevention activities are referenced?
The description references prevention interventions such as risk reduction education and other evidence-based prevention approaches suited to closed and high-risk settings like prisons.
How does the opportunity address linkage to care after HIV testing?
It specifically calls for HIV testing services with effective linkage to care, signaling that testing is expected to connect people to clinical services rather than operate as a stand-alone activity.
Does the program include HIV treatment like antiretroviral therapy (ART)?
Yes. Clinical treatment services are included, and antiretroviral therapy for HIV is explicitly referenced.
What does the opportunity say about keeping people engaged in treatment over time?
It emphasizes ongoing care and support to help individuals remain engaged in treatment, recognizing that continuity can be disrupted in prison settings by transfers, releases, or resource constraints.
How are TB services expected to be handled within this program?
TB services are a major pillar and are expected to be integrated with HIV programming. "Comprehensive" TB services are described as generally including systematic screening and evaluation for TB symptoms, diagnostic testing pathways, appropriate treatment initiation and follow-up, and prevention strategies such as infection control measures in facilities.
Why is TB integrated with HIV services in this opportunity?
The description points to the well-established relationship between HIV and TB co-infection and the high burden of TB in congregate settings like prisons. Integration is presented as a way to avoid fragmented care for co-infected patients and improve coordinated management.
What prison-specific challenges does the opportunity highlight?
It highlights that prisons can have elevated transmission risks and that continuity of care can be disrupted by transfers, releases, and resource constraints. It also references crowded conditions and the need for facility-level procedures to detect TB quickly and reduce transmission.
How many awards does CDC expect to make under this opportunity?
The listing indicates an expected single award (ExpectedAwards: 1), suggesting CDC anticipated funding one implementing partner.
Does the opportunity publish an award ceiling amount?
The award ceiling is listed as 0, which the description explains can indicate that a specific ceiling was not published in the synopsis or is defined elsewhere in the full announcement or continuation documentation.
What is the CFDA number and category for this opportunity?
It is categorized as a health activity under CFDA 93.067.
When was the application closing date?
The closing date for applications was December 16, 2015 (noted as both the original and current closing date).
When was the notice created and posted?
The notice was created and posted on December 8, 2015.
What does the short time window between posting and closing suggest?
The description characterizes the short turnaround as typical of continuation actions where eligible applicants may be limited and the goal is uninterrupted service delivery.
Who is eligible to apply?
Eligibility is described broadly as "Others," with direction to consult the additional eligibility text in the full announcement for specifics.
Is eligibility likely to be restricted because this is a continuation?
The description notes that in continuation cooperative agreements, eligibility is often restricted to organizations already funded under the preceding project period or those meeting narrow criteria tied to the existing program. This aligns with the single expected award and continuation category, but the exact eligibility requirements are referenced as being in the full announcement.
What is the overall intent of CDC Uganda under this opportunity?
The opportunity is described as CDC Uganda, under PEPFAR, maintaining and improving a national-level prison HIV/TB program by funding one partner to deliver and coordinate prevention, testing, treatment, and support services for prisoners and prison staff, while strengthening prison systems for consistent identification, linkage, treatment sustainment, and follow-up.
Browse more opportunities from the same agency: HHS-CDC
Browse more opportunities from the same category: Health
Next opportunity: NEA Literature (Poetry) Fellowships, FY2017
Previous opportunity: Joint Conservation, Park Improvement, Youth Employment and Education Activities
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 159002CONT16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 159002CONT16) also looked into and applied for these:
| Funding Opportunity |
|---|
| NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01) Apply for PAR 16 021 Funding Number: PAR 16 021 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Limited Competition: Pediatric Heart Network for the Data Coordinating Center (U24) Apply for RFA HL 17 005 Funding Number: RFA HL 17 005 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Emergency Medical Services for Children Innovation and Improvement Center Apply for HRSA 16 052 Funding Number: HRSA 16 052 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Statewide Family Network Program Apply for SM 16 004 Funding Number: SM 16 004 Agency: HHS-SAMHS Category: Health Funding Amount: $95,000 |
| State Offices of Rural Health Grant Program (SORH) Apply for HRSA 16 016 Funding Number: HRSA 16 016 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Precision Medicine Initiative Cohort Program Healthcare Provider Organization Enrollment Centers (UG3/UH3) Apply for RFA PM 16 002 Funding Number: RFA PM 16 002 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| National State-Based Tobacco Control Programs Apply for CDC RFA DP15 150902CONT16 Funding Number: CDC RFA DP15 150902CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| NIH Director's Early Independence Awards (DP5) Apply for RFA RM 15 006 Funding Number: RFA RM 15 006 Agency: HHS-NIH11 Category: Health Funding Amount: $250,000 |
| Pre-clinical Research Based on Existing Repurposing Tools Apply for RFA TR 16 001 Funding Number: RFA TR 16 001 Agency: HHS-NIH11 Category: Health Funding Amount: $250,000 |
| Precision Medicine Initiative Cohort Program Participant Technologies Center (U24) Apply for RFA PM 16 003 Funding Number: RFA PM 16 003 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Noncommunicable Disease Prevention and Health Promotion in the Region of the Americas, PAHO Apply for CDC RFA GH15 161802CONT16 Funding Number: CDC RFA GH15 161802CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Pediatric Heart Network Clinical Research Centers (UG1) Apply for RFA HL 17 004 Funding Number: RFA HL 17 004 Agency: HHS-NIH11 Category: Health Funding Amount: $220,000 |
| MCH Pipeline Training Program Apply for HRSA 16 037 Funding Number: HRSA 16 037 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Ensuring Adequate Access to HIV/AIDS Screening, Care and Treatment to Key Populations in Haiti under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1682 Funding Number: CDC RFA GH16 1682 Agency: HHS-CDC-CGH Category: Health Funding Amount: $1,200,000 |
| Supporting the National Blood Transfusion Service (NBTS) in the implementation and expansion of Blood Safety activities in the Republic of Zambia under the President’s Emergency plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1709 Funding Number: CDC RFA GH16 1709 Agency: HHS-CDC Category: Health Funding Amount: $1,353,644 |
| Strengthening HIV/AIDS Prevention and Care Services for Highly Vulnerable Populations in the Republic of Côte d’Ivoire Under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10310501SUPP16 Funding Number: CDC RFA PS10 10310501SUPP16 Agency: HHS-CDC Category: Health Funding Amount: $3,123,298 |
| National Child Traumatic Stress Initiative, National Center for Child Traumatic Stress Apply for SM 16 003 Funding Number: SM 16 003 Agency: HHS-SAMHS Category: Health Funding Amount: $6,000,000 |
| Service Area Competition – Additional Areas (SAC-AA) – California, District of Columbia, Kansas, Nevada, New York, Oregon, Texas, and Washington Apply for HRSA 16 176 Funding Number: HRSA 16 176 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Service Area Competition – Additional Area (SAC-AA) – Baltimore, Maryland Apply for HRSA 16 177 Funding Number: HRSA 16 177 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| B Cell Immunology Program for HIV-1 Vaccine Development (BCIP) (R01) Apply for RFA AI 15 055 Funding Number: RFA AI 15 055 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 159002CONT16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.